Your browser doesn't support javascript.
loading
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer.
Kummar, Shivaani; Wade, James L; Oza, Amit M; Sullivan, Daniel; Chen, Alice P; Gandara, David R; Ji, Jiuping; Kinders, Robert J; Wang, Lihua; Allen, Deborah; Coyne, Geraldine O'Sullivan; Steinberg, Seth M; Doroshow, James H.
Afiliação
  • Kummar S; National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.
  • Wade JL; The University of Chicago Medical Center, Chicago, IL, USA.
  • Oza AM; Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.
  • Sullivan D; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Chen AP; National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.
  • Gandara DR; University of California Davis Cancer Center, Davis, CA, USA.
  • Ji J; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Kinders RJ; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Wang L; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Allen D; National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.
  • Coyne GO; National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.
  • Steinberg SM; National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.
  • Doroshow JH; National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA. doroshoj@mail.nih.gov.
Invest New Drugs ; 34(3): 355-63, 2016 06.
Article em En | MEDLINE | ID: mdl-26996385

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Ciclofosfamida / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Ciclofosfamida / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos